Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr Dileep Nair received his medical degree in 1993 from Northeastern Ohio Medical University, formally known as NEOUCOM. He went on to do his neurology residency and clinical neurophysiology and epilepsy fellowship at Cleveland Clinic. He served as the chief resident in his neurology residency as well as chief epilepsy fellow. After his fellowship in 1999, he held joint appointments in the epilepsy section at Cleveland Clinic as well as the Neurology department at MetroHealth Medical Center. He was also appointed the director of the EEG lab as well as the intraoperative monitoring unit at MetroHealth Medical Center from 1999 to 2004. In 2004, he became a full time staff at Cleveland Clinic Epilepsy Center and served as their Director of intraoperative monitoring program. In 2003 Dr Nair became the fellowship director for clinical neurophysiology and epilepsy fellowship and in 2007 he became the ACGME fellowship director for both EEG and EMG fellowships, a position he held until 2010. Dr Nair became the section head of adult epilepsy at Cleveland Clinic in 2008. Currently, Dr Nair is the section head of adult epilepsy and directory of intraoperative neurophysiologic monitoring at Cleveland Clinic.
Dr Nair has over 30 peer reviewed journal articles in journals such as Brain, Neurology, Neurosurgery, Human Brain Mapping, Epilepsia, Clinical Neurophysiology, and Epileptic Disorders. In addition, he has written several book chapters and invited reviews articles. He has also written a book titled Epilepsy: An Atlas of Investigation and Management. His publications have been in the areas of human brain connectivity, invasive EEG recordings, brain stimulation and clinical neurophysiology.
Medical and surgical management of adult and geriatric epilepsy, intraoperative monitoring of the brain and other parts of the nervous system mapping connections in the human brain
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/19/2015, Dr. Nair has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.